A carregar...
Dihydrofolate reductase as a predictor for poor response to platinum-based chemotherapy in epithelial ovarian cancer
Background: Platinum-based chemotherapy is the first line chemotherapy regimen for ovarian cancer patients. However, chemotherapy resistance is observed in a large proportion of patients. It is urgently needed to investigate prognostic biomarkers for chemo-sensitivity in ovarian cancer. Methods: Dih...
Na minha lista:
| Publicado no: | Int J Clin Exp Pathol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
e-Century Publishing Corporation
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6947109/ https://ncbi.nlm.nih.gov/pubmed/31933990 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|